Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome

NCT00932100 is registered in ClinicalTrials.gov with Regado Biosciences, Inc. as lead sponsor.

NCT NCT00932100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00932100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome
Lead sponsor
Regado Biosciences, Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2009
Completion date
January 31, 2011
Enrollment
640 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome (acs)